Scientific Advisory Group

Our Scientific Advisory Group (SAG) is composed of 11 scientists from across the US and 6 experts from relevant government agencies, including the DEA, Centers for Disease Control and Prevention (CDC), and the Food and Administration (FDA) to advise NDEWS leadership regarding relevant indicators, data harmonization, and interpretation.


NDEWS SAG Members

Name Title and Organization
Joseph Palamar, PhD SAG Chair, NDEWS Deputy Director, Associate Professor, Department of Population Health, New York University Langone Medical Center
Farida Ahmad, MPH Mortality Surveillance Lead, Division of Vital Statistics, National Center for Health Statistics, Centers for Disease Control and Prevention
Erin Artigiani, MA Deputy Director, Center for Substance Abuse Research (CESAR), University of Maryland
Georgiy Bobashev, PhD RTI Senior Fellow, Center for Data Science, RTI International
Thomas Carr Executive Director, University of Baltimore Center for Drug Policy and Enforcement; Senior Fellow, George Mason University Center for Evidence-Based Crime Policy; Washington/Baltimore High Intensity Drug Trafficking Area (HIDTA)
Dan Ciccarone, MD, MPH Professor, Family Community Medicine, School of Medicine, University of California, San Francisco
Suparna Das, PhD Director, Office of Treatment Services (OTS), Center for Behavioral Health Statistics and Quality (CBHSQ), U.S. Department of Health and Human Services (DHHS)/Substance Abuse and Mental Health Services Administration (SAMHSA)
Matthew Ellis, PhD, MPE Principal Investigator, RADARS System; Department of Psychiatry, Washington University School of Medicine in St. Louis
Jim Hall, PhD Epidemiologist, Center for Applied Research on Substance Use and Health Disparities, Nova Southeastern University
Jennifer R. Havens, PhD, MPH Epidemiologist, Professor in the Department of Behavioral Science, College of Medicine, University of Kentucky
Lee Hoffer, PhD, MPE Associate Professor, Anthropology; Director of Graduate Programs; Professor, Psychiatry, Case Western Reserve University School of Medicine
Emily Lockhart, MS Senior Forensic Chemist, Special Testing and Research Laboratory, former Emerging Trends Program member, Drug Enforcement Administration (DEA)
Barry K Logan, PhD, F-ABFT Senior VP of Forensic Sciences, Chief Scientist, NMS Labs; Executive Director, Center for Forensic Science Research and Education (CFSRE); Adjunct Professor at Thomas Jefferson University, Forensic Toxicology Program
Jana McAninch, MD, MPH, MS Senior Medical Epidemiologist, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration (FDA)
Julie O’Donnell, PhD, MPH Epidemiologist, Division of Overdose Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention (CDC)
Amit Sheth, PhD Founding Director, Artificial Intelligence Institute; Professor, Computer Science and Engineering, University of South Carolina
Katie Witkiewitz, PhD Director of the Center on Alcohol, Substance use, And Addictions (CASAA), Regent’s Professor, Department of Psychology, University of New Mexico

Last modified: 03/08/2024

The National Drug Early Warning System (NDEWS) is funded by the National Institute on Drug Abuse (U01DA051126) to the University of Florida (PI: Cottler; Co-Is: Goldberger, Nixon, Striley), New York University (Deputy Director: Palamar), and Florida Atlantic University (Co-I: Barenholtz).